- Contract for up to $14.3 million for 15,325 Courses - NEW YORK , April 03, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Canadian Department of National Defence

- Announces Expectations for Product Delivery to BARDA - - Announces $50 Million Share Repurchase Program - - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK , March 05, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company

SIGA to supply TPOXX ® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK , March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it

NEW YORK , Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.